Business Segments and Geographical Information

12 Months Ended

Dec. 30, 2023

Segment Reporting [Abstract]

Business Segments and Geographical Information

15. Business Segments and Geographical Information

We operate in one segment, ophthalmology. Substantially all of our long-term assets are located in the U.S. We develop, manufacture and market medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service and support activities.

Revenue information shown by product is as follows (in thousands):

	FY 2023		FY 2022
	Year Ended		Year Ended
	December 30, 2023		December 31, 2022
Cyclo G6	$	13,461	$	14,694
Retina		29,445		31,657
Other(1)		8,963		10,621
Total revenues	$	51,869	$	56,972

(1) Includes service contract revenues of $1,534 thousand and $1,509 thousand recognized during fiscal years 2023 and 2022, respectively. Includes $1,455 thousand and $1,348 thousand recognized revenue related to the exclusive distribution rights during fiscal years 2023 and 2022. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region is as follows (in thousands):

	FY 2023		FY 2022
	Year Ended		Year Ended
	December 30, 2023		December 31, 2022
United States	$	26,054	$	29,179
Europe, Middle East and Africa		13,519		13,801
Asia/Pacific Rim		10,234		10,931
Americas, excluding the U.S.		2,062		3,061
	$	51,869	$	56,972

Revenues are attributed to countries based on location of end customers.

Other than the United States, The Netherlands accounted for more than 10% of the Company’s revenues during fiscal year 2023, representing 14.0%. The United States accounted for 50.2% of revenues in 2023. Other than the United States, The Netherlands accounted for more than 10% of the Company’s revenues during fiscal year 2022, representing 14.4%. The United States accounted for 51.2% of revenues in 2022.